ILC3 function as a double-edged sword in inflammatory bowel diseases

Boning Zeng, Shengnan Shi, Gareth Ashworth, Changjiang Dong, Jing Liu, Feiyue Xing

Research output: Contribution to journalArticlepeer-review

164 Citations (Scopus)
31 Downloads (Pure)


Inflammatory bowel diseases (IBD), composed mainly of Crohn’s disease (CD) and ulcerative colitis (UC), are strongly implicated in the development of intestinal inflammation lesions. Its exact etiology and pathogenesis are still undetermined. Recently accumulating evidence supports that group 3 innate lymphoid cells (ILC3) are responsible for gastrointestinal mucosal homeostasis through moderate generation of IL-22, IL-17, and GM-CSF in the physiological state. ILC3 contribute to the progression and aggravation of IBD while both IL-22 and IL-17, along with IFN-γ, are overexpressed by the dysregulation of NCR− ILC3 or NCR+ ILC3 function and the bias of NCR+ ILC3 towards ILC1 as well as regulatory ILC dysfunction in the pathological state. Herein, we feature the group 3 innate lymphoid cells’ development, biological function, maintenance of gut homeostasis, mediation of IBD occurrence, and potential application to IBD therapy.
Original languageEnglish
Article number315
JournalCell Death & Disease
Issue number4
Publication statusPublished - 8 Apr 2019

Cite this